Search research articles
Contact Us
Filters
Showing results (41-50 of 60) with videos related to
Page
of 6
Sort By:
Leukemia
|
August 17, 2012
The clinical relevance of BAALC and ERG expression levels in pediatric AML
M C H Hermkens, M M van den Heuvel-Eibrink, S T C J M Arentsen-Peters, et al.
Familial Cancer
|
May 29, 2024
Optimizing the detection of hereditary predisposition in women with epithelial ovarian cancer: nationwide implementation of the Tumor-First workflow
Vera M Witjes, Dorien M A Hermkens, Julie E M Swillens, et al.
Acta Neuropathologica Communications
|
October 16, 2019
Profiling the unique protective properties of intracranial arterial endothelial cells
Dorien M A Hermkens, Olga C G Stam, Nienke M de Wit, et al.
Familial Cancer
|
May 15, 2022
Healthcare professionals' perspectives on implementation of universal tumor DNA testing in ovarian cancer patients: multidisciplinary focus groups
Vera M Witjes, Jozé C C Braspenning, Nicoline Hoogerbrugge, et al.
Antimicrobial Agents and Chemotherapy
|
July 24, 2013
Combination of pantothenamides with vanin inhibitors as a novel antibiotic strategy against gram-positive bacteria
Patrick A M Jansen, Pedro H H Hermkens, Patrick L J M Zeeuwen, et al.
British Journal of Haematology
|
March 26, 2013
NADH dehydrogenase subunit 4 variant sequences in childhood acute myeloid leukaemia
Michael A Morgan, Birgit Markus, Malou Hermkens, et al.
Cardiovascular Research
|
October 11, 2017
Cgnl1, an endothelial junction complex protein, regulates GTPase mediated angiogenesis
Ihsan Chrifi, Dorien Hermkens, Maarten M Brandt, et al.
Haematologica
|
January 18, 2015
BCOR and BCORL1 mutations in pediatric acute myeloid leukemia
Jasmijn D E de Rooij, Marry M van den Heuvel-Eibrink, Malou C H Hermkens, et al.
Journal of Medicinal Chemistry
|
September 20, 2011
Discovery and optimization of 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives as a novel class of selective cannabinoid CB2 receptor agonists
Mario van der Stelt, Jos Cals, Silvia Broeders-Josten, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
June 4, 2016
A New Ir-NHC Catalyst for Signal Amplification by Reversible Exchange in D2 O
Peter Spannring, Indrek Reile, Meike Emondts, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 60) with videos related to
Sort By:
Page
of 6
Leukemia
|
August 17, 2012
The clinical relevance of BAALC and ERG expression levels in pediatric AML
M C H Hermkens, M M van den Heuvel-Eibrink, S T C J M Arentsen-Peters, et al.
Familial Cancer
|
May 29, 2024
Optimizing the detection of hereditary predisposition in women with epithelial ovarian cancer: nationwide implementation of the Tumor-First workflow
Vera M Witjes, Dorien M A Hermkens, Julie E M Swillens, et al.
Acta Neuropathologica Communications
|
October 16, 2019
Profiling the unique protective properties of intracranial arterial endothelial cells
Dorien M A Hermkens, Olga C G Stam, Nienke M de Wit, et al.
Familial Cancer
|
May 15, 2022
Healthcare professionals' perspectives on implementation of universal tumor DNA testing in ovarian cancer patients: multidisciplinary focus groups
Vera M Witjes, Jozé C C Braspenning, Nicoline Hoogerbrugge, et al.
Antimicrobial Agents and Chemotherapy
|
July 24, 2013
Combination of pantothenamides with vanin inhibitors as a novel antibiotic strategy against gram-positive bacteria
Patrick A M Jansen, Pedro H H Hermkens, Patrick L J M Zeeuwen, et al.
British Journal of Haematology
|
March 26, 2013
NADH dehydrogenase subunit 4 variant sequences in childhood acute myeloid leukaemia
Michael A Morgan, Birgit Markus, Malou Hermkens, et al.
Cardiovascular Research
|
October 11, 2017
Cgnl1, an endothelial junction complex protein, regulates GTPase mediated angiogenesis
Ihsan Chrifi, Dorien Hermkens, Maarten M Brandt, et al.
Haematologica
|
January 18, 2015
BCOR and BCORL1 mutations in pediatric acute myeloid leukemia
Jasmijn D E de Rooij, Marry M van den Heuvel-Eibrink, Malou C H Hermkens, et al.
Journal of Medicinal Chemistry
|
September 20, 2011
Discovery and optimization of 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives as a novel class of selective cannabinoid CB2 receptor agonists
Mario van der Stelt, Jos Cals, Silvia Broeders-Josten, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
June 4, 2016
A New Ir-NHC Catalyst for Signal Amplification by Reversible Exchange in D2 O
Peter Spannring, Indrek Reile, Meike Emondts, et al.
Page
of 6